| Name | Zansecimab |
|---|
| Description | Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |